Glymera

Glymera Uses, Dosage, Side Effects, Food Interaction and all others data.

Glymera is under investigation in clinical trial NCT01658501 (Phase 2b Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM).

Trade Name Glymera
Generic Glymera
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Glymera
Glymera

Innovators Monograph

You find simplified version here Glymera


*** Taking medicines without doctor's advice can cause long-term problems.
Share